Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards

Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards Accessibility StatementSkip Navigation INCHEON, South Korea, March 26, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), received recognition at the 2026 CDMO Leadership Awards presented by Outsourced Pharma and Life Science Connect. The company was awarded the Sustainability Leadership Award, a jury-selected distinction recognizing efforts ...